These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 9066965)

  • 1. Do postvaccinal sarcomas occur in Australian cats?
    Burton G; Mason KV
    Aust Vet J; 1997 Feb; 75(2):102-6. PubMed ID: 9066965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Questions long-term immunity in cats.
    Norsworthy GD
    J Am Vet Med Assoc; 1999 Aug; 215(3):316-7. PubMed ID: 10434959
    [No Abstract]   [Full Text] [Related]  

  • 3. Questions efficacy of vaccinating cats at 3-year intervals.
    Norsworthy GD
    Am J Vet Res; 1999 Aug; 60(8):918-9. PubMed ID: 10451196
    [No Abstract]   [Full Text] [Related]  

  • 4. Onset of immunity in kittens after vaccination with a non-adjuvanted vaccine against feline panleucopenia, feline calicivirus and feline herpesvirus.
    Jas D; Aeberlé C; Lacombe V; Guiot AL; Poulet H
    Vet J; 2009 Oct; 182(1):86-93. PubMed ID: 18694649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feline panleukopenia virus, feline herpesvirus-1 and feline calicivirus antibody responses in seronegative specific pathogen-free kittens after parenteral administration of an inactivated FVRCP vaccine or a modified live FVRCP vaccine.
    Lappin MR
    J Feline Med Surg; 2012 Feb; 14(2):161-4. PubMed ID: 22314095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reaction rate in cats vaccinated with a new controlled-titer feline panleukopenia-rhinotracheitis-calicivirus-Chlamydia psittaci vaccine.
    Starr RM
    Cornell Vet; 1993 Oct; 83(4):311-23. PubMed ID: 8306654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine site-associated sarcomas in cats: clinical experience and a laboratory review (1982-1993).
    Lester S; Clemett T; Burt A
    J Am Anim Hosp Assoc; 1996; 32(2):91-5. PubMed ID: 8680926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined administration in a single injection of a feline multivalent modified live vaccine against FHV, FCV, and FPLV together with a recombinant FeLV vaccine is both safe and efficacious for all four major feline viral pathogens.
    Kanellos T; Sutton DJ; Salisbury CF; Chalmers WS
    J Feline Med Surg; 2008 Aug; 10(4):346-54. PubMed ID: 18448375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feline postvaccinal sarcoma: 20 years later.
    Wilcock B; Wilcock A; Bottoms K
    Can Vet J; 2012 Apr; 53(4):430-4. PubMed ID: 23024394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-year duration of immunity in cats following vaccination against feline rhinotracheitis virus, feline calicivirus, and feline panleukopenia virus.
    Gore TC; Lakshmanan N; Williams JR; Jirjis FF; Chester ST; Duncan KL; Coyne MJ; Lum MA; Sterner FJ
    Vet Ther; 2006; 7(3):213-22. PubMed ID: 17039444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential role of inflammation in the development of postvaccinal sarcomas in cats.
    Macy DW; Hendrick MJ
    Vet Clin North Am Small Anim Pract; 1996 Jan; 26(1):103-9. PubMed ID: 8825569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of maternally-derived antibodies on serologic responses to vaccination in kittens.
    Digangi BA; Levy JK; Griffin B; Reese MJ; Dingman PA; Tucker SJ; Dubovi EJ
    J Feline Med Surg; 2012 Feb; 14(2):118-23. PubMed ID: 22314087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postvaccination sarcomas in cats.
    Esplin DG; McGill LD; Meininger AC; Wilson SR
    J Am Vet Med Assoc; 1993 Apr; 202(8):1245-7. PubMed ID: 8496079
    [No Abstract]   [Full Text] [Related]  

  • 14. Safety and efficacy of a recombinant FeLV vaccine combined with a live feline rhinotracheitis, calicivirus and panleukopenia vaccine.
    Gueguen S; Martin V; Bonnet L; Saunier D; Mähl P; Aubert A
    Vet Rec; 2000 Mar; 146(13):380-1. PubMed ID: 10803986
    [No Abstract]   [Full Text] [Related]  

  • 15. Feline panleukopenia virus, feline herpesvirus-1, and feline calicivirus antibody responses in seronegative specific pathogen-free cats after a single administration of two different modified live FVRCP vaccines.
    Lappin MR; Veir J; Hawley J
    J Feline Med Surg; 2009 Feb; 11(2):159-62. PubMed ID: 18782676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term immunity in cats vaccinated with an inactivated trivalent vaccine.
    Scott FW; Geissinger CM
    Am J Vet Res; 1999 May; 60(5):652-8. PubMed ID: 10328440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. More on efficacy of vaccinating cats at 3-year intervals.
    Ellis JA
    Am J Vet Res; 1999 Sep; 60(9):1035-6. PubMed ID: 10490067
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevalence of serum antibody titers against feline panleukopenia virus, feline herpesvirus 1, and feline calicivirus in cats entering a Florida animal shelter.
    DiGangi BA; Levy JK; Griffin B; McGorray SP; Dubovi EJ; Dingman PA; Tucker SJ
    J Am Vet Med Assoc; 2012 Nov; 241(10):1320-5. PubMed ID: 23113524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A field trial to assess the effect of vaccination against feline herpesvirus, feline calicivirus and feline panleucopenia virus in 6-week-old kittens.
    Dawson S; Willoughby K; Gaskell RM; Wood G; Chalmers WS
    J Feline Med Surg; 2001 Mar; 3(1):17-22. PubMed ID: 11716626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. World Wide Web-based survey of vaccination practices, postvaccinal reactions, and vaccine site-associated sarcomas in cats.
    Gobar GM; Kass PH
    J Am Vet Med Assoc; 2002 May; 220(10):1477-82. PubMed ID: 12018373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.